Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 46Recruiting 16Active not recruiting 12Terminated 10Withdrawn 4Unknown 3

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Lymphoma, Large B-Cell, Diffuse 26Lymphoma 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Leukemia 11Neuroblastoma 10Lymphoma, Non-Hodgkin 10Central Nervous System Neoplasms 8Lymphoma, Follicular 6Hodgkin Disease 6Sarcoma 5Retinoblastoma 5Lymphoma, T-Cell, Peripheral 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Immunoblastic Lymphadenopathy 4Wilms Tumor 3Oligodendroglioma 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Kidney Neoplasms 3Burkitt Lymphoma 3Astrocytoma 3Recurrence 2Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms, Plasma Cell 2Neoplasms 2Multiple Myeloma 2Leukemia, T-Cell 2Leukemia, Biphenotypic, Acute 2Enteropathy-Associated T-Cell Lymphoma 2

Interventions

Cyclophosphamide 18fludarabine 7Rituximab 7Etoposide 7Cytarabine 7Radiotherapy 5Peripheral Blood Stem Cell Transplantation 5Melphalan 5Filgrastim 5Cyclosporine 4Cisplatin 4fludarabine phosphate 3epratuzumab 3Vincristine 3Prednisone 3Methylprednisolone 3Indium 3Immunotherapy, Adoptive 3Doxorubicin 3Dexamethasone 3Busulfan 3Antilymphocyte Serum 3sargramostim 2Radioimmunodetection 2Paclitaxel 2Mycophenolic Acid 2Methotrexate 2Lym-1 monoclonal antibody 2Ifosfamide 2Hydrocortisone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Burkitt Lymphoma × Vincristine × Clear all
NCT02481310 2022-02-21

Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma

Northwestern University

Phase 1/2 Unknown
38 enrolled 12 charts
Lymphoid

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05049473 2021-09-20

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

PETHEMA Foundation

Phase 2 Unknown
100 enrolled
Lymphoid

Burkitt Lymphoma

NCT00005959 2013-12-04

Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 2 Unknown
Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡